Interview with Stefan Brinkmann, General Manager, Nycomed Germany
How challenging is for you as General Manager of Nycomed Germany to lead the number one subsidiary of the Nycomed Group and what would you highlight as the key milestones…
Address: Zeppelinstrasse 2-4, 64625 Bensheim-Germany
Tel: +49 62 51 84 84 102
Web: http://www.cegedim.com/Pages/default.aspx
Cegedim Dendrite is the leading provider of pharmaceutical CRM, pharmaceutical data, direct marketing pharmaceuticals and pharmaceutical services worldwide. The Cegedim Group works with over 8,000 employees in 80 countries and generates annual sales of 849 million euros, with excellent growth prospects for the coming years.
In Germany, it has approximately 200 employees and offers the German pharmaceutical industry with operational CRM systems TEAMS, Mobile Intelligence, directly to the analytic CRM tool PPM (Pharma Performance Manager) and the address database OneKey, the reference database the German health system.
Pharmaceutical CRM, pharmaceutical data, direct marketing pharmaceuticals and pharmaceutical services
How challenging is for you as General Manager of Nycomed Germany to lead the number one subsidiary of the Nycomed Group and what would you highlight as the key milestones…
The acquisition of IVAX in 2006 was decisive to establish Teva as the number one generic producer worldwide and further consolidate the company in the German market; and this process…
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Cytonet is today Germany’s largest cell therapy enterprise. However, it went through many transformations since its spin-off from Roche Diagnostics in 2000. Could you briefly introduce the company to our…
The German Pharmaceutical Industry is not only known for its cutting-edge R&D and production base but also for having a high penetration of generics. In your opinion, what role do…
You have a wide experience in the pharmaceutical industry having worked for companies such as Amgen and Servier. What attracted you to Basilea? When I first considered moving to Basilea…
When we met Dr. Aleiotti in Italy, he said how important was Menarini´s acquisition of Berlin Chemie in the 1990s for the internationalization of the company in Eastern Europe and…
With a wide experience in other international pharmaceutical companies, what attracted you to come to Bausch&Lomb, the ophthalmology pharma company? Bausch&Lomb offered me a unique set of challenges and possibilities…
See our Cookie Privacy Policy Here
